Ceinsys Tech Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 8:02 pm

Quick Insight

Ceinsys Tech Ltd, operating in the IT Consulting & Software industry, displays a robust intrinsic value at a share price of 1,881 with a market capitalization of 3,356 Cr. The company's financial health is underscored by a P/E ratio of 40.4, ROE of 19.6%, and ROCE of 26.2%. With a healthy operating profit margin of 19% and a net profit of 63 Cr, Ceinsys Tech Ltd shows promising profitability. However, the high P/BV ratio of 5.77x suggests the stock may be overvalued. Additionally, the negative CCC of -540 days indicates potential inefficiencies in working capital management. Investors should closely monitor these metrics to make informed decisions on Ceinsys Tech Ltd's stock, considering its strong ICR of 35.58x as a buffer against financial risks.

Competitors of Ceinsys Tech Ltd

All Competitor Stocks of Ceinsys Tech Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:35 am

Below is a detailed analysis of the quarterly data for Ceinsys Tech Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 142.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 15.00 Cr..
• For Expenses, as of Jun 2025, the value is 126.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.00 Cr. (Mar 2025) to 126.00 Cr., marking an increase of 10.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 34.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 23.00% (Mar 2025) to 7.00%, marking a decrease of 16.00%.
• For Net Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 10.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 18.14. The value appears strong and on an upward trend. It has increased from 12.54 (Mar 2025) to 18.14, marking an increase of 5.60.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:03 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:36 pm

Below is a detailed analysis of the balance sheet data for Ceinsys Tech Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2024) to 17.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 394.00 Cr.. The value appears strong and on an upward trend. It has increased from 218.00 Cr. (Mar 2024) to 394.00 Cr., marking an increase of 176.00 Cr..
• For Borrowings, as of Mar 2025, the value is 49.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 40.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 117.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 83.00 Cr. (Mar 2024) to 117.00 Cr., marking an increase of 34.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 578.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 326.00 Cr. (Mar 2024) to 578.00 Cr., marking an increase of 252.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 82.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 38.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 22.00 Cr..
• For Other Assets, as of Mar 2025, the value is 473.00 Cr.. The value appears strong and on an upward trend. It has increased from 239.00 Cr. (Mar 2024) to 473.00 Cr., marking an increase of 234.00 Cr..
• For Total Assets, as of Mar 2025, the value is 578.00 Cr.. The value appears strong and on an upward trend. It has increased from 326.00 Cr. (Mar 2024) to 578.00 Cr., marking an increase of 252.00 Cr..

Notably, the Reserves (394.00 Cr.) exceed the Borrowings (49.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Ceinsys Tech Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 37.37. This value is within the healthy range. It has increased from 22.52 (Mar 24) to 37.37, marking an increase of 14.85.
• For Diluted EPS (Rs.), as of Mar 25, the value is 35.27. This value is within the healthy range. It has increased from 22.52 (Mar 24) to 35.27, marking an increase of 12.75.
• For Cash EPS (Rs.), as of Mar 25, the value is 34.88. This value is within the healthy range. It has increased from 17.34 (Mar 24) to 34.88, marking an increase of 17.54.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 236.17. It has increased from 143.26 (Mar 24) to 236.17, marking an increase of 92.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 236.17. It has increased from 143.26 (Mar 24) to 236.17, marking an increase of 92.91.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 239.71. It has increased from 154.80 (Mar 24) to 239.71, marking an increase of 84.91.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 51.40. This value is within the healthy range. It has increased from 29.20 (Mar 24) to 51.40, marking an increase of 22.20.
• For PBIT / Share (Rs.), as of Mar 25, the value is 46.69. This value is within the healthy range. It has increased from 26.04 (Mar 24) to 46.69, marking an increase of 20.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 45.25. This value is within the healthy range. It has increased from 23.15 (Mar 24) to 45.25, marking an increase of 22.10.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 30.17. This value is within the healthy range. It has increased from 14.18 (Mar 24) to 30.17, marking an increase of 15.99.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 36.26. This value is within the healthy range. It has increased from 21.42 (Mar 24) to 36.26, marking an increase of 14.84.
• For PBDIT Margin (%), as of Mar 25, the value is 21.44. This value is within the healthy range. It has increased from 18.85 (Mar 24) to 21.44, marking an increase of 2.59.
• For PBIT Margin (%), as of Mar 25, the value is 19.47. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 19.47, marking an increase of 2.66.
• For PBT Margin (%), as of Mar 25, the value is 18.87. This value is within the healthy range. It has increased from 14.95 (Mar 24) to 18.87, marking an increase of 3.92.
• For Net Profit Margin (%), as of Mar 25, the value is 12.58. This value exceeds the healthy maximum of 10. It has increased from 9.16 (Mar 24) to 12.58, marking an increase of 3.42.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.12. This value is within the healthy range. It has increased from 13.83 (Mar 24) to 15.12, marking an increase of 1.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.35. This value is within the healthy range. It has increased from 14.95 (Mar 24) to 15.35, marking an increase of 0.40.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.41. This value is within the healthy range. It has increased from 17.85 (Mar 24) to 19.41, marking an increase of 1.56.
• For Return On Assets (%), as of Mar 25, the value is 10.94. This value is within the healthy range. It has increased from 10.73 (Mar 24) to 10.94, marking an increase of 0.21.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.09, marking an increase of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.92. It has increased from 0.79 (Mar 24) to 0.92, marking an increase of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 2.61 (Mar 24) to 2.82, marking an increase of 0.21.
• For Quick Ratio (X), as of Mar 25, the value is 2.81. This value exceeds the healthy maximum of 2. It has increased from 2.60 (Mar 24) to 2.81, marking an increase of 0.21.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.81 (Mar 24) to 0.00, marking a decrease of 8.81.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.68 (Mar 24) to 0.00, marking a decrease of 7.68.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.19 (Mar 24) to 0.00, marking a decrease of 91.19.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.32 (Mar 24) to 0.00, marking a decrease of 92.32.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 35.58. This value is within the healthy range. It has increased from 10.13 (Mar 24) to 35.58, marking an increase of 25.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 21.88. This value is within the healthy range. It has increased from 5.92 (Mar 24) to 21.88, marking an increase of 15.96.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,254.25. It has increased from 936.84 (Mar 24) to 2,254.25, marking an increase of 1,317.41.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.39. This value exceeds the healthy maximum of 3. It has increased from 3.70 (Mar 24) to 5.39, marking an increase of 1.69.
• For EV / EBITDA (X), as of Mar 25, the value is 25.14. This value exceeds the healthy maximum of 15. It has increased from 19.64 (Mar 24) to 25.14, marking an increase of 5.50.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.68. This value exceeds the healthy maximum of 3. It has increased from 3.80 (Mar 24) to 5.68, marking an increase of 1.88.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.18 (Mar 24) to 0.00, marking a decrease of 91.18.
• For Price / BV (X), as of Mar 25, the value is 5.77. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 5.77, marking an increase of 1.66.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.68. This value exceeds the healthy maximum of 3. It has increased from 3.80 (Mar 24) to 5.68, marking an increase of 1.88.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness